Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Vigilance safely keeps AFib patients off anticoagulants post ablation

Publish date:: January 27, 2020

Key clinical point: A program of heightened, regular surveillance has allowed selected atrial fibrillation patients who are arrhythmia free following catheter ablation to stop anticoagulation treatment.

Major finding: During 576 patient-years of follow-up, no patients had a cerebrovascular event related to atrial arrhythmia.

Study details: Review of prospectively collected data from 190 patients who participated at a single U.S. center.

Disclosures: Dr. Marchlinski has been a consultant to or has received honoraria from Abbott EP/St. Jude, Biosense Webster, Biotronik, Boston Scientific, and Medtronic.

Citation:

REPORTING FROM THE AF SYMPOSIUM 2020

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Stroke

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,

Hypertension often goes undertreated in patients with a history of stroke,

Higher stroke rates seen among patients with COVID-19 compared with influenza,

Updated AAN advisory outlines when PFO closure may be option for patients with stroke,

Silent brain infarcts found in 3% of AFib patients, tied to cognitive decline,